Sonoma Pharmaceuticals (SNOA) Change in Account Payables (2010 - 2025)
Sonoma Pharmaceuticals (SNOA) recorded quarterly Change in Account Payables of $229000.0 in Q4 2025, up 134.38% quarter-over-quarter from -$666000.0 in Q3 2025, and down 64.5% on a YoY basis from $645000.0 in Q4 2024.
Sonoma Pharmaceuticals (SNOA) Change in Account Payables (2010 - 2025) Analysis & Trends
Sonoma Pharmaceuticals' Change in Account Payables history runs 16 years deep, the most recent figure standing at $229000.0 for Q4 2025.
- In Q4 2025, Change in Account Payables fell 64.5% year-over-year to $229000.0; the TTM figure through Dec 2025 stood at $141000.0 (down 76.42% YoY), while the FY2025 annual figure was $416000.0, up 249.64% from the prior year.
- Change in Account Payables was $229000.0 for Q4 2025 at Sonoma Pharmaceuticals, up from -$666000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $1.0 million in Q2 2025 to a low of -$981000.0 in Q3 2022.
- Historically, Change in Account Payables has averaged -$46100.0 across 5 years, with a median of $30000.0 in 2021.
- The sharpest annual moves came in 2022 and 2025: Change in Account Payables jumped 1410.71% in 2022, then sank 1900.0% in 2025.
- A 5-year view of Change in Account Payables shows it stood at -$288000.0 in 2021, then jumped by 171.18% to $205000.0 in 2022, then plunged by 170.24% to -$144000.0 in 2023, then surged by 547.92% to $645000.0 in 2024, then sank by 64.5% to $229000.0 in 2025.
- The last three Change in Account Payables figures came in at $229000.0 (Q4 2025), -$666000.0 (Q3 2025), and $1.0 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 167.64 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 190,000.00 |
| 10 | Sonoma Pharmaceuticals | 1.90 Mn | -659,569.98 | 1.65 Mn | 229,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 229,000.00 |
| Dec 31, 2025 | 229,000.00 |
| Sep 30, 2025 | -666,000.00 |
| Sep 30, 2025 | -666,000.00 |
| Jun 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | -448,000.00 |
| Mar 31, 2025 | -448,000.00 |
| Dec 31, 2024 | 645,000.00 |
| Dec 31, 2024 | 645,000.00 |
| Sep 30, 2024 | 37,000.00 |
| Sep 30, 2024 | 37,000.00 |
| Jun 30, 2024 | 182,000.00 |
| Jun 30, 2024 | 182,000.00 |
| Mar 31, 2024 | -266,000.00 |
| Mar 31, 2024 | -266,000.00 |
| Dec 31, 2023 | -144,000.00 |
| Dec 31, 2023 | -144,000.00 |
| Sep 30, 2023 | -82,000.00 |
| Sep 30, 2023 | -82,000.00 |